“…The imperative for an ad hoc randomized study, with a larger sample size tailored on the oncological outcomes, coupled with the need to address intersurgeon variabilities, is evident for achieving statistically significant results in this context. Other studies have explored this research question, and despite being summarized in various systematic reviews and meta-analyses, a conclusive answer is still elusive [ 4 , 35 , 36 , 37 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 ]. Moreover, primary research studies face various limiting factors, including missing data, a low sample size, and inadequate comparisons that combine rectosigmoid cancers with true rectal cancers.…”